US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist

673.600
-0.670-0.10%

Close Feb 14 16:00 ET

673.600
0.0000.00%

Post 20:01 ET

73.64BMarket Cap17.57P/E (TTM)

Regeneron Pharmaceuticals Key Stats

Regeneron Pharmaceuticals Q4 2024 Earnings Date

Currency：USDFeb 4, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	3.75B	3.79B	+43.03M
Beat Est.	+9.08%	+10.33%	+1.15%
EPS	9.07	8.06	-1.01
Miss Est.	-10.99%	-20.90%	-11.14%

Analyst Rating

Buy

Feb 14, 2025

Regeneron Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 3.612B	--
--	2025/Q1	-- / 3.430B	--
Feb 4, 2025	2024/Q4	3.789B / 3.746B	--
Oct 31, 2024	2024/Q3	3.721B / 3.667B	--
Aug 1, 2024	2024/Q2	3.547B / 3.387B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 3.612B--

--2025/Q1-- / 3.430B--

Feb 4, 20252024/Q43.789B / 3.746B--

Oct 31, 20242024/Q33.721B / 3.667B--

Aug 1, 20242024/Q23.547B / 3.387B--

Unlock Free Earnings Estimates

Open Account

Regeneron Pharmaceuticals Earnings Reports

Regeneron Pharmaceuticals | 10-K: FY2024 Annual Report

Feb 5 09:20 ET

Regeneron Pharmaceuticals | 8-K: Regeneron Reports Fourth Quarter and Full Year 2024 Financial and Operating Results; Initiates Quarterly Dividend and Increases Total Share Repurchase Capacity to ~$4.5 Billion

Feb 4 08:30 ET

Regeneron Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Oct 31, 2024 07:21 ET

Regeneron Pharmaceuticals | 8-K: Regeneron Reports Third Quarter 2024 Financial and Operating Results

Oct 31, 2024 07:15 ET

REGN Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Regeneron Pharmaceuticals Q4 2024 Earnings Date

Regeneron Pharmaceuticals Earnings Estimates

Regeneron Pharmaceuticals Earnings Reports

Trending Stocks